Basic Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Science and ICT(No.NRF-2023R1A2C2005946).Korean NRF did not influence the drafting of the manuscript.
For intermediate-stage hepatocellular carcinoma(HCC)in the Barcelona Clinic Liver Cancer(BCLC),transarterial chemoembolization(TACE)is advised as the initial treatment.The term“BCLC intermediate-stage HCC”(BCLC stag...
Intrahepatic cholangiocarcinoma(iCCA)is the second most common type of liver cancer after hepatocellular carcinoma,accounting for 15%of all primary liver neoplasms.In particular,iCCA is the most lethal tumor of these ...
Cholangiocarcinoma(CCA)represents a group of epithelial cell tumors classified based on their anatomic location along the biliary tree.This rare malignancy is often diagnosed at an advanced stage and deemed unresectab...
Background and Objective:With the development of novel active systemic therapies,the landscape of hepatocellular carcinoma(HCC)management is rapidly changing.However,HCC lacks sensitive and specific biomarkers to pred...
The diagnosis and monitoring of disease through the detection of circulating protein biomarkers is a growing field in the practice of oncology.The search for more effective protein biomarkers to aid in the diagnosis a...
supported by project grants from the National Natural Science Foundation of China(Nos.91859105,and 81961128025);the Program of Shanghai Academic Research Leader(No.19XD1420700);the Science and Technology Commission of Shanghai Municipality(No.20JC1418900);the Shanghai Municipal Key Clinical Specialty.
Background:Intrahepatic cholangiocarcinoma(ICC)is a highly metastatic cancer.^(18)F-fluorodeoxyglucose positron emission tomography/computed tomography(^(18)F-FDG PET/CT)enables sensitive tumor and metastasis detectio...
supported by Italian Ministry of Health-Ricerca Corrente Annual Program 2023.
We really appreciated Lin et al.’s“The influence of ^(18)F-fluorodeoxyglucose positron emission tomography/computed tomography on the N-and M-staging and subsequent clinical management of intrahepatic cholangiocarci...
Pancreatic ductal adenocarcinoma(PDAC)is a disease with a particular aggressive cancer biology and,unfortunately,a very poor prognosis for most patients.There is no question about the lethality of pancreatic cancer.Ho...
Importance:In the past few decades,there has been rapid advancements in imaging technologies that have become irreplaceable in the pre-operative assessment of patients with pancreatic tumors.Modern imaging modalities,...